IL-5/IL-13 drive NLRP3 inflammasome-mediated, steroid-resistant AHR in a model of obesity-associated asthma
J. Pinkerton (London, United Kingdom), R. Kim (Newcastle, Australia), A. Brown (Newcastle, Australia), B. Rae (Newcastle, Australia), J. Mayall (Newcastle, Australia), M. Ali (Newcastle, Australia), M. Starkey (Newcastle, Australia), A. Robertson (Brisbane, Australia), L. Wood (Newcastle, Australia), M. Cooper (Brisbane, Australia), L. O'Neill (Dublin, Ireland), P. Hansbro (Sydney, Australia), J. Horvat (Newcastle, Australia)
Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Pinkerton (London, United Kingdom), R. Kim (Newcastle, Australia), A. Brown (Newcastle, Australia), B. Rae (Newcastle, Australia), J. Mayall (Newcastle, Australia), M. Ali (Newcastle, Australia), M. Starkey (Newcastle, Australia), A. Robertson (Brisbane, Australia), L. Wood (Newcastle, Australia), M. Cooper (Brisbane, Australia), L. O'Neill (Dublin, Ireland), P. Hansbro (Sydney, Australia), J. Horvat (Newcastle, Australia). IL-5/IL-13 drive NLRP3 inflammasome-mediated, steroid-resistant AHR in a model of obesity-associated asthma. 3345
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: